Scholastic Posts Downbeat Q1 Results, Joins Legacy Education, Zscaler And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

QUICK SPARK: Michael Burry Adds to Micron, Palantir, Nebius, SOXX Shorts

Michael Burry increased his short positions in Micron, Nebius, SOXX and Palantir, while adding to five consumer and retail stocks.

Shares of professional services companies are trading higher, possibly in response to Accenture's Q4 financial results. Accenture's performance may indicate growth within the sector.

Synopsys, Accenture, Vicor And Other Big Stocks Moving Higher On Thursday

U.S. stocks fell Thursday, but Synopsys surged 10.8% on strong FY27 guidance. Accenture, Enerflex and other shares also posted notable gains.

Company News for Oct 1, 2026

Recent economic data shows PCE inflation came in softer than expected while Q2 GDP exceeded expectations. Market attention is focused on the upcoming Friday employment report. Several companies reported earnings results with mixed stock performance: FactSet Research Systems beat earnings estimates and gained 3.8%, Concentrix outpaced estimates with a modest 0.3% gain, Hewlett Packard Enterprise surged 3.9% following a $1.2 billion deal with Vultr, while Mattel declined 4.2% after announcing a new CEO.

Why Concentrix Stock Ended Up Moving Higher Today

Concentrix stock initially fell 8.6% after reporting a fiscal Q3 revenue miss, but recovered to close up 2.83% as investors refocused on the company's earnings beat. The revenue shortfall reflects customer preference shifts toward lower-cost AI solutions rather than fundamental business deterioration, with management guiding for a 3-5% revenue decline in Q4.

Chardan Capital Maintains Buy on 4D Molecular Therapeutics, Lowers Price Target to $25

Chardan Capital analyst Gautam Chukka maintains 4D Molecular Therapeutics (NASDAQ:FDMT) with a Buy and lowers the price target from $26 to $25.